LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | 6.0 | 1.0 | 3.0 | 918.0 | 372.0 | 7.0 | - | - | 1307 |
1 | - | - | - | - | - | 3.0 | 7.0 | 1.0 | - | - | 11 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 71.0 |
1 | - |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 633 |
1 | 842 |
Number of post synapses: 1307
Number of pre synapses: 11
Number of output connections: 19
Coverage factor: 1.0
Columnar completeness: 0.33
Area completeness: 0.54
Cell size (columns): 297
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#aMe25 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | MeVPMe4 (L) | Glu | 289 | 289.0 | 20.6% | 20.6% |
1 | Mi10 (R) | ACh | 172 | 172.0 | 12.2% | 32.8% |
2 | Mi15 (R) | ACh | 156 | 156.0 | 11.1% | 43.9% |
3 | Dm2 (R) | ACh | 113 | 113.0 | 8.0% | 52.0% |
4 | Tm5c (R) | Glu | 104 | 104.0 | 7.4% | 59.4% |
5 | MeTu1 (R) | ACh | 77 | 77.0 | 5.5% | 64.8% |
6 | Cm12 (R) | GABA | 54 | 54.0 | 3.8% | 68.7% |
7 | MeVPMe11 (L) | Glu | 37 | 37.0 | 2.6% | 71.3% |
8 | TmY10 (R) | ACh | 33 | 33.0 | 2.3% | 73.7% |
9 | MeTu3b (R) | ACh | 29 | 29.0 | 2.1% | 75.7% |
10 | MeLo3b (R) | ACh | 27 | 27.0 | 1.9% | 77.7% |
11 | aMe17b (R) | GABA | 26 | 26.0 | 1.9% | 79.5% |
12 | MeVP1 (R) | ACh | 24 | 24.0 | 1.7% | 81.2% |
13 | MeVC2 (L) | ACh | 21 | 21.0 | 1.5% | 82.7% |
14 | aMe5 (R) | ACh | 19 | 19.0 | 1.4% | 84.1% |
15 | MeTu3c (R) | ACh | 17 | 17.0 | 1.2% | 85.3% |
16 | Cm33 (R) | GABA | 14 | 14.0 | 1.0% | 86.3% |
17 | aMe9 (R) | ACh | 12 | 12.0 | 0.9% | 87.1% |
18 | aMe12 (R) | ACh | 10 | 10.0 | 0.7% | 87.8% |
19 | Cm31b (R) | GABA | 10 | 10.0 | 0.7% | 88.5% |
20 | Cm20 (R) | GABA | 9 | 9.0 | 0.6% | 89.2% |
21 | Cm2 (R) | ACh | 8 | 8.0 | 0.6% | 89.8% |
22 | aMe12 (L) | ACh | 7 | 7.0 | 0.5% | 90.2% |
23 | Tm39 (R) | ACh | 7 | 7.0 | 0.5% | 90.7% |
24 | Cm3 (R) | GABA | 6 | 6.0 | 0.4% | 91.2% |
25 | Cm31a (R) | GABA | 6 | 6.0 | 0.4% | 91.6% |
26 | MeVP12 (R) | ACh | 6 | 6.0 | 0.4% | 92.0% |
27 | MeVPMe3 (L) | Glu | 6 | 6.0 | 0.4% | 92.5% |
28 | aMe10 (L) | ACh | 5 | 5.0 | 0.4% | 92.8% |
29 | Cm17 (R) | GABA | 5 | 5.0 | 0.4% | 93.2% |
30 | MeLo3a (R) | ACh | 5 | 5.0 | 0.4% | 93.5% |
31 | Cm7 (R) | Glu | 4 | 4.0 | 0.3% | 93.8% |
32 | MeLo1 (R) | ACh | 4 | 4.0 | 0.3% | 94.1% |
33 | MeVC6 (L) | ACh | 4 | 4.0 | 0.3% | 94.4% |
34 | Tm37 (R) | Glu | 4 | 4.0 | 0.3% | 94.7% |
35 | aMe17a (R) | Glu | 3 | 3.0 | 0.2% | 94.9% |
36 | Cm1 (R) | ACh | 3 | 3.0 | 0.2% | 95.1% |
37 | Cm9 (R) | Glu | 3 | 3.0 | 0.2% | 95.3% |
38 | MeVC11 (L) | ACh | 3 | 3.0 | 0.2% | 95.5% |
39 | MeVPaMe2 (L) | Glu | 3 | 3.0 | 0.2% | 95.7% |
40 | Tm34 (R) | Glu | 3 | 3.0 | 0.2% | 95.9% |
41 | TmY20 (R) | ACh | 3 | 3.0 | 0.2% | 96.2% |
42 | Cm14 (R) | GABA | 2 | 2.0 | 0.1% | 96.3% |
43 | Cm28 (R) | unclear | 2 | 2.0 | 0.1% | 96.4% |
44 | Cm30 (R) | GABA | 2 | 2.0 | 0.1% | 96.6% |
45 | MeVP3 (R) | ACh | 2 | 2.0 | 0.1% | 96.7% |
46 | MeVP33 (R) | ACh | 2 | 2.0 | 0.1% | 96.9% |
47 | MeVP41 (R) | ACh | 2 | 2.0 | 0.1% | 97.0% |
48 | MeVP7 (R) | ACh | 2 | 2.0 | 0.1% | 97.2% |
49 | MeVP9 (R) | ACh | 2 | 2.0 | 0.1% | 97.3% |
50 | MeVPaMe1 (R) | ACh | 2 | 2.0 | 0.1% | 97.4% |
51 | MeVPLo2 (R) | ACh | 2 | 2.0 | 0.1% | 97.6% |
52 | MeVPMe2 (L) | Glu | 2 | 2.0 | 0.1% | 97.7% |
53 | Mi9 (R) | Glu | 2 | 2.0 | 0.1% | 97.9% |
54 | OA-AL2i4 (R) | OA | 2 | 2.0 | 0.1% | 98.0% |
55 | OLVC4 (L) | unclear | 2 | 2.0 | 0.1% | 98.1% |
56 | 5-HTPMPV01 (L) | unclear | 1 | 1.0 | 0.1% | 98.2% |
57 | 5-HTPMPV03 (L) | 5HT | 1 | 1.0 | 0.1% | 98.3% |
58 | aMe17e (R) | Glu | 1 | 1.0 | 0.1% | 98.4% |
59 | Cm16 (R) | Glu | 1 | 1.0 | 0.1% | 98.4% |
60 | Cm21 (R) | GABA | 1 | 1.0 | 0.1% | 98.5% |
61 | Cm34 (R) | Glu | 1 | 1.0 | 0.1% | 98.6% |
62 | Cm5 (R) | GABA | 1 | 1.0 | 0.1% | 98.6% |
63 | Cm6 (R) | GABA | 1 | 1.0 | 0.1% | 98.7% |
64 | Cm8 (R) | GABA | 1 | 1.0 | 0.1% | 98.8% |
65 | Dm3b (R) | Glu | 1 | 1.0 | 0.1% | 98.9% |
66 | LoVP46 (R) | Glu | 1 | 1.0 | 0.1% | 98.9% |
67 | LoVP96 (R) | Glu | 1 | 1.0 | 0.1% | 99.0% |
68 | MeLo6 (R) | ACh | 1 | 1.0 | 0.1% | 99.1% |
69 | MeTu3a (R) | ACh | 1 | 1.0 | 0.1% | 99.1% |
70 | MeTu4d (R) | ACh | 1 | 1.0 | 0.1% | 99.2% |
71 | MeVC10 (L) | ACh | 1 | 1.0 | 0.1% | 99.3% |
72 | MeVC5 (L) | ACh | 1 | 1.0 | 0.1% | 99.4% |
73 | MeVP14 (R) | ACh | 1 | 1.0 | 0.1% | 99.4% |
74 | MeVP21 (R) | ACh | 1 | 1.0 | 0.1% | 99.5% |
75 | MeVP49 (R) | unclear | 1 | 1.0 | 0.1% | 99.6% |
76 | MeVP59 (R) | ACh | 1 | 1.0 | 0.1% | 99.6% |
77 | MeVP6 (R) | Glu | 1 | 1.0 | 0.1% | 99.7% |
78 | MeVPMe2 (R) | Glu | 1 | 1.0 | 0.1% | 99.8% |
79 | MeVPMe5 (L) | Glu | 1 | 1.0 | 0.1% | 99.9% |
80 | MeVPMe9 (L) | Glu | 1 | 1.0 | 0.1% | 99.9% |
81 | Mi17 (R) | GABA | 1 | 1.0 | 0.1% | 100.0% |
instance | NT | total connections | connections /#aMe25 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | LoVP60 (R) | unclear | 15 | 15.0 | 16.7% | 16.7% |
1 | MeVP1 (R) | ACh | 10 | 10.0 | 11.1% | 27.8% |
2 | LT55 (R) | Glu | 9 | 9.0 | 10.0% | 37.8% |
3 | MeVP29 (R) | ACh | 6 | 6.0 | 6.7% | 44.4% |
4 | PS272 (R) | unclear | 6 | 6.0 | 6.7% | 51.1% |
5 | aMe20 (R) | unclear | 4 | 4.0 | 4.4% | 55.6% |
6 | LoVCLo2 (R) | unclear | 4 | 4.0 | 4.4% | 60.0% |
7 | LoVP12 (R) | unclear | 3 | 3.0 | 3.3% | 63.3% |
8 | LoVP65 (R) | unclear | 2 | 2.0 | 2.2% | 65.6% |
9 | LoVP67 (R) | unclear | 2 | 2.0 | 2.2% | 67.8% |
10 | MeTu4a (R) | ACh | 2 | 2.0 | 2.2% | 70.0% |
11 | MeVC24 (R) | Glu | 2 | 2.0 | 2.2% | 72.2% |
12 | aMe10 (R) | ACh | 1 | 1.0 | 1.1% | 73.3% |
13 | aMe15 (R) | unclear | 1 | 1.0 | 1.1% | 74.4% |
14 | aMe9 (R) | ACh | 1 | 1.0 | 1.1% | 75.6% |
15 | Cm1 (R) | ACh | 1 | 1.0 | 1.1% | 76.7% |
16 | Cm10 (R) | GABA | 1 | 1.0 | 1.1% | 77.8% |
17 | Cm3 (R) | GABA | 1 | 1.0 | 1.1% | 78.9% |
18 | Cm5 (R) | GABA | 1 | 1.0 | 1.1% | 80.0% |
19 | Dm2 (R) | ACh | 1 | 1.0 | 1.1% | 81.1% |
20 | LC37 (R) | Glu | 1 | 1.0 | 1.1% | 82.2% |
21 | LoVP37 (R) | unclear | 1 | 1.0 | 1.1% | 83.3% |
22 | LoVP73 (R) | unclear | 1 | 1.0 | 1.1% | 84.4% |
23 | LoVP96 (R) | Glu | 1 | 1.0 | 1.1% | 85.6% |
24 | MeTu3b (R) | ACh | 1 | 1.0 | 1.1% | 86.7% |
25 | MeTu4f (R) | ACh | 1 | 1.0 | 1.1% | 87.8% |
26 | MeVC3 (L) | ACh | 1 | 1.0 | 1.1% | 88.9% |
27 | MeVP48 (R) | unclear | 1 | 1.0 | 1.1% | 90.0% |
28 | MeVP9 (R) | ACh | 1 | 1.0 | 1.1% | 91.1% |
29 | MeVPMe5 (R) | Glu | 1 | 1.0 | 1.1% | 92.2% |
30 | MeVPMe6 (R) | Glu | 1 | 1.0 | 1.1% | 93.3% |
31 | MeVPMe9 (R) | Glu | 1 | 1.0 | 1.1% | 94.4% |
32 | Mi15 (R) | ACh | 1 | 1.0 | 1.1% | 95.6% |
33 | Tm34 (R) | Glu | 1 | 1.0 | 1.1% | 96.7% |
34 | Tm5a (R) | ACh | 1 | 1.0 | 1.1% | 97.8% |
35 | Tm5c (R) | Glu | 1 | 1.0 | 1.1% | 98.9% |
36 | Tm9 (R) | ACh | 1 | 1.0 | 1.1% | 100.0% |